Literature DB >> 16043406

The influence of aetiology on inflammatory and neurohumoral activation in patients with severe heart failure: a prospective study comparing Chagas' heart disease and idiopathic dilated cardiomyopathy.

Amilcar O Mocelin1, Victor S Issa, Fernando Bacal, Guilherme V Guimarães, Edecio Cunha, Edimar A Bocchi.   

Abstract

Patients with Chagas' cardiomyopathy have the worst prognosis when compared to other aetiologies. It has been suggested that a more intense inflammatory activation could be responsible for this excessive mortality. We studied 35 patients with idiopathic dilated cardiomyopathy (IDC group) and 28 patients with Chagas' heart disease (Chagas' group) and 12 control subjects. We compared plasma tumor necrosis factor alpha (TNF-alpha), soluble TNF-alpha receptor type 1 (sTNF-R1), soluble Fas (sFas), interleukin 6 (IL-6), and brain natriuretic peptide type B (BNP) concentrations between the groups. TNF-alpha and IL-6 concentrations were higher in the IDC and Chagas groups as compared to controls (p<0.001 and p=0.001, respectively). sTNF-R1 concentration was higher in IDC after stratification for functional class (p=0.039), and there was a trend toward higher plasma TNF-alpha concentration in the Chagas' group (p=0.092). IL-6 concentration was higher in Chagas than in IDC (p=0.005). Higher IL-6 levels were associated with worse outcome (p=0.03 for Chagas; p=0.003 for IDC). sFas concentration was similar among groups. BNP concentrations were higher in IDC (350 pg/ml) and in Chagas (444.6 pg/ml) as compared to the controls (20.3 pg/ml; p<0.01). Higher BNP levels were associated with death and heart transplantation in both aetiologies. Inflammatory activation in Chagas heart disease differs from IDC and is associated with heart failure severity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043406     DOI: 10.1016/j.ejheart.2004.10.014

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  12 in total

1.  Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease.

Authors:  S M Keating; X Deng; F Fernandes; E Cunha-Neto; A L Ribeiro; B Adesina; A I Beyer; P Contestable; B Custer; M P Busch; E C Sabino
Journal:  Int J Cardiol       Date:  2015-07-12       Impact factor: 4.164

Review 2.  Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.

Authors:  Silvia Gilka Muñoz-Saravia; Annekathrin Haberland; Gerd Wallukat; Ingolf Schimke
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 3.  Chagas Cardiomyopathy in Latin America Review.

Authors:  Jefferson Luis Vieira; Fábio Rocha Fernandes Távora; Maria Gyslane Vasconcelos Sobral; Glauber Gean Vasconcelos; Germana Porto Linhares Almeida; Juliana Rolim Fernandes; Laura Leite da Escóssia Marinho; Daniel Francisco de Mendonça Trompieri; João David De Souza Neto; Juan Alberto Cosquillo Mejia
Journal:  Curr Cardiol Rep       Date:  2019-02-12       Impact factor: 3.955

4.  The Indeterminate Form of Chagas Disease.

Authors:  Victor Sarli Issa
Journal:  Arq Bras Cardiol       Date:  2018-02       Impact factor: 2.000

5.  Measurement of multiple cytokines for discrimination and risk stratification in patients with Chagas' disease and idiopathic dilated cardiomyopathy.

Authors:  Yong Wang; Niels Wessel; Franziska Kohse; Adnan Khan; Heinz-Peter Schultheiss; Maria da Consolaҫão V Moreira; Thomas Walther
Journal:  PLoS Negl Trop Dis       Date:  2021-03-23

6.  The course of patients with Chagas heart disease during episodes of decompensated heart failure.

Authors:  Victor Sarli Issa; Silvia Moreira Ayub-Ferreira; Matthew Schroyens; Paulo Roberto Chizzola; Paulo Rogerio Soares; Silvia Helena Gelas Lage; Edimar Alcides Bocchi
Journal:  ESC Heart Fail       Date:  2021-02-17

Review 7.  Heart failure in South America.

Authors:  Edimar Alcides Bocchi
Journal:  Curr Cardiol Rev       Date:  2013-05

8.  Elevated serum levels of macrophage migration inhibitory factor are associated with progressive chronic cardiomyopathy in patients with Chagas disease.

Authors:  Romina A Cutrullis; Patricia B Petray; Edgardo Schapachnik; Rubén Sánchez; Miriam Postan; Mariela N González; Valentina Martín; Ricardo S Corral
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

9.  Polymorphism in the alpha cardiac muscle actin 1 gene is associated to susceptibility to chronic inflammatory cardiomyopathy.

Authors:  Amanda Farage Frade; Priscila Camilo Teixeira; Barbara Maria Ianni; Cristina Wide Pissetti; Bruno Saba; Lin Hui Tzu Wang; Andréia Kuramoto; Luciana Gabriel Nogueira; Paula Buck; Fabrício Dias; Helene Giniaux; Agnes Llored; Sthefanny Alves; Andre Schmidt; Eduardo Donadi; José Antonio Marin-Neto; Mario Hirata; Marcelo Sampaio; Abílio Fragata; Edimar Alcides Bocchi; Antonio Noedir Stolf; Alfredo Inacio Fiorelli; Ronaldo Honorato Barros Santos; Virmondes Rodrigues; Alexandre Costa Pereira; Jorge Kalil; Edecio Cunha-Neto; Christophe Chevillard
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

10.  Plasma cytokine profile in tropical endomyocardial fibrosis: predominance of TNF-a, IL-4 and IL-10.

Authors:  Aline S Bossa; Vera M C Salemi; Susan P Ribeiro; Daniela S Rosa; Ludmila Rodrigues Pinto Ferreira; Suzete C Ferreira; Anna Shoko Nishiya; Charles Mady; Jorge Kalil; Edecio Cunha-Neto
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.